Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Antibiotics played an important role in controlling the development of enteric infection.
However, the emergence of antibiotic resistance and gut dysbiosis led to a growing interest …

To date, seven identified coronaviruses (CoVs) have been found to infect humans; of these,
three highly pathogenic variants have emerged in the 21st century. The newest member of …

SARS‐CoV‐2 is a novel human coronavirus responsible for the Coronavirus disease 2019
(COVID‐19) pandemic. Pneumonia and acute respiratory distress syndrome are the major …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …

The attention to polymer-based biomaterials, for instance, chitosan and its derivatives, as
well as the techniques for using them in numerous scientific domains, is continuously rising …

Chitosan is an abundant organic polysaccharide, which can be relatively easily obtained by
chemical modification of animal or fungal source materials. Chitosan and its derivatives …

Chitosan is a biodegradable natural polymer derived from the exoskeleton of crustaceans.
Because of its biocompatibility and non-biotoxicity, chitosan is widely used in the fields of …

COVID-19 pandemic results in record high deaths in many countries. Although a vaccine for
SARS-CoV-2 is now available, effective antiviral drugs to treat coronavirus diseases are not …

The progressive and fatal outbreak of the newly emerged coronavirus, SARS-CoV-2,
necessitates rigorous collaboration of all health care systems and researchers from all …